Effect of estrogen on bone resorption and inflammation in the temporomandibular joint cellular elements

International Journal of Molecular Medicine

Volumn 21, Issue 6, 2008, Pages 785-790

  Galal, Nadia ^a,b   El Beialy, Waleed ^a,b   Deyama, Yoshiaki ^a   Yoshimura, Yoshitaka ^a   Yoshikawa, Tetsuya ^a   Suzuki, Kuniaki ^a   Totsuka, Yasunori ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b MSA University   (Egypt)

Author keywords

Macrophage colonization; MCSF; Osteoprotegerin; Temporomandibular disorder

Indexed keywords

COLONY STIMULATING FACTOR 1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN C FMS; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; COLONY STIMULATING FACTOR RECEPTOR; MESSENGER RNA; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SEX HORMONE;

AGED; ANIMAL CELL; ARTHRITIS; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FIBROBLAST; GROWTH REGULATION; HEMATOPOIETIC STEM CELL; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; OSTEOLYSIS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; TEMPOROMANDIBULAR JOINT DISORDER; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; INFLAMMATION; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIUM; TEMPOROMANDIBULAR JOINT; TUMOR CELL LINE;

AGED; ANIMALS; BLOTTING, WESTERN; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; ESTROGENS; FEMALE; FIBROBLASTS; GENE EXPRESSION; GONADAL STEROID HORMONES; HUMANS; INFLAMMATION; MACROPHAGE COLONY-STIMULATING FACTOR; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNOVIAL MEMBRANE; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 47649090985     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.6.785     Document Type: Article

References (36)

1. Galand P, Leroy F and Chretien J: Effect of estradiol on cell proliferation and histological changes in the uterus and vagina of mice. J Endocrinol 49: 243-252, 1971.
2. Pavao M and Traish AM: Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor α and β. Steroids 66: 1-16, 2001.
3. Fryer CJ, Kinyamu HK, Rogatsky I, Garabedian MJ and Archer TK: Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells. J Biol Chem 275: 17771-17777, 2000.
4. Kuttila M, Niemi PM, Kuttila S, Alanen P and Le Bell Y: TMD treatment need in relation to age, gender, stress, and diagnostic subgroup. J Orofac Pain 12: 67-74, 1998.
5. Campbell JH, Courey MS, Bourne P and Odziemiec C: Estrogen receptor analysis of human temporomandibular disc. J Oral Maxillofac Surg 51: 1101-1105, 1993.
6. Le Resche L: Epidemiology of temporomandibular disorders: implications for the investigation of etiologic factors. Crit Rev Oral Biol Med 8: 291-305, 1997.
7. Kapila S and Xie Y: Targeted induction of collagenase and stromelysin by relaxin in unprimed and beta-estradiol-primed diarthrodial joint fibrocartilaginous cells but not in synoviocytes. Lab Invest 78: 925-938, 1998.
8. Ushiyama T, Inoue K and Nishioka J: Expression of estrogen receptor related protein (p29) and estradiol binding in human arthritic synovium. J Rheumatol 22: 421-426, 1995.
9. Khalkhali-Ellis Z, Seftor EA, Nieva DR, Handa RJ, Price RH Jr, Kirschmann DA, Baragi VM, Sharma RV, Bhalla RC, Moore TL and Hendrix MJ: Estrogen and progesterone regulation of human fibroblast-like synoviocytes function in vitro: implications in rheumatoid arthritis. J Rheumatol 27: 1622-1631, 2000.
10. Warren MP and Fried JL: Temporomandibular disorders and hormones in women. Cells Tissues Organs 169: 187-192, 2001.
11. Barland P, Novikoff AB and Hamerman D: Electron microscopy of the human synovial membrane. J Cell Biol 14: 207-220, 1962.
12. Morstyn G and Burgess AW: Hemopoietic growth factors: a review. Cancer Res 48: 5624-5637, 1988.
13. Hamilton JA, Stanley ER, Burgess AW and Shadduck RK: Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol 103: 435-445, 1980.
14. Wing EJ, Ampel NM, Waheed A and Shadduck RK: Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products. J Immunol 135: 2052-2056, 1985.
15. Warren MK and Ralph P: Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol 137: 2281-2285, 1986.
16. Fuller K, Owens JM, Wilson A, Moss R and Chambers TJ: Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 178: 1733-1744, 1993.
17. Lacey DL, Timms E, Tan HL, Kelly MJ, Dunstan CR, Burgess T, Elliot R, Colombero A. Elliot G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Elli A, Qian YX, Kaufman S, Sarosi I. Shalhoub V, Senaldi G, Guo J, Delany J and Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176, 1998.
18. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-santos AJ, Van G. Itei A. Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ and Penninger JM: OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323, 1999.
19. Simonet WS, Lacey DL, Dunstan CR, Kelly MJ, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeR ose M, Elliot R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R and Boyle WJ: Osteoprotegerin a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319, 1997.
20. Mitani M. Miura Y, Saura R, Kitagawa A, Fukuyama T. Hashiramoto A, Shiozawa S, Kurosaka M and Yoshiya S: Estrogen specifically stimulates expression and production of osteoprotegerin from rheumatoid synovial fibroblasts. Int J Mol Med 15: 827-832, 2005.
21. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS, Frankel WN, Lee SY and Choi Y: TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272: 25190-25194, 1997.
22. Fata JE, Kong YY, Li J, Sasaki T, Irie-Sasaki J, Moorehead RA, Elliott R, Scully S, Voura EB, Lacey DL, Boyle WJ, Khokha R and Penninger JM: The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103: 41-50, 2000.
23. Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlöndorff J, Tempst P, Choi Y and Blobel CP: Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha) converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 274: 13613-13618, 1999.
24. Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H and Sakai H: Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun 275: 768-775, 2000.
25. Kartsogiannis V, Zhou H, Horwood NJ, Thomas RJ, Hards DK, Quinn JM, Niforas P, Ng KW, Martin TJ and Gillespie MT: Localization of RANKL (receptor activator of NFκB ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone 25: 525-534, 1999.
26. Lagasse E and Weissman IL: Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89: 1021-1031, 1997.
27. Shevde NK, Bendixen AC, Dienger KM and Pike JW: Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 97: 7829-7834, 2000.
28. Villa I, Mrak E, Rubinacci A, Ravasi F and Guidobono F: CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/ PKA-dependent pathway. Am J Physiol Cell Physiol 291: 529-537, 2006.
29. Abubaker AO, Raslan WF and Sotereanos GC: Estrogen and progesterone receptors in temporomandibular joint discs of symptomatic and asymptomatic persons: a preliminary study. J Oral Maxillofac Surg 51: 1096-1100, 1993.
30. Galal N, El-Beialy WR, Deyama Y, Yoshimura Y, Suzuki K and Totsuka Y: Novel effect of estrogen on RANK and c-fms in RAW 264.7 cells. Int J Mol Med 20: 97-101, 2007.
31. Claassen H, Hassenpflug J, Schunke M, Sierralta W, Thole H and Kurz B: Immunohistochemical detection of estrogen receptor α in articular chondrocytes from cows, pigs and humans: in situ and in vitro results. Ann Anat 183: 223-227, 2001.
32. Palacios VG, Robinson LJ, Borysenko CW, Lehmann T, Kalla SE and Blair HC: Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 cells by estrogen and phytoestrogens. J Biol Chem 14: 13720-13727, 2005.
33. Shevde NK and Pike JW: Estrogen modulates the recruitment of myelopoietic cell progenitors in rat through a stromal cell-independent mechanism involving apoptosis. Blood 87: 2683-2692, 1996.
34. Fiorelli G, Gori F, Petilli M, Tanini A, Benvenuti S, Serio M, Bernabei P and Brandi ML: Functional estrogen receptors in a human preosteoclastic cell Line. Proc Natl Acad Sci USA 92: 2672-2676, 1995.
35. Cao I, Bu R, Oakley JI, Kalla SE and Blair HC: Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells. J Cell Biochem 89: 152-164, 2003.
36. Bord S, Ireland DC, Beavan SR and Compston JE: The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 32: 136-141, 2003.